1Q41

GSK-3 Beta complexed with Indirubin-3'-monoxime


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.229 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Structural Characterization of the Gsk-3Beta Active Site Using Selective and Non-selective ATP-Mimetic Inhibitors

Bertrand, J.A.Thieffine, S.Vulpetti, A.Cristiani, C.Valsasina, B.Knapp, S.Kalisz, H.M.Flocco, M.

(2003) J Mol Biol 333: 393-407

  • DOI: https://doi.org/10.1016/j.jmb.2003.08.031
  • Primary Citation of Related Structures:  
    1PYX, 1Q3D, 1Q3W, 1Q41, 1Q4L

  • PubMed Abstract: 

    GSK-3beta is a regulatory serine/threonine kinase with a plethora of cellular targets. Consequently, selective small molecule inhibitors of GSK-3beta may have a variety of therapeutic uses including the treatment of neurodegenerative diseases, type II diabetes and cancer. In order to characterize the active site of GSK-3beta, we determined crystal structures of unphosphorylated GSK-3beta in complex with selective and non-selective ATP-mimetic inhibitors. Analysis of the inhibitors' interactions with GSK-3beta in the structures reveals how the enzyme can accommodate a number of diverse molecular scaffolds. In addition, a conserved water molecule near Thr138 is identified that can serve a functional role in inhibitor binding. Finally, a comparison of the interactions made by selective and non-selective inhibitors highlights residues on the edge of the ATP binding-site that can be used to obtain inhibitor selectivity. Information gained from these structures provides a promising route for the design of second-generation GSK-3beta inhibitors.


  • Organizational Affiliation

    Department of Chemistry, Pharmacia Italia SpA, Discovery Research Oncology, Viale Pasteur, 10, 20014 Nerviano, Italy. jay.bertrand@pharmacia.com


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
GLYCOGEN SYNTHASE KINASE-3 BETA
A, B
424Homo sapiensMutation(s): 0 
Gene Names: GSK3B
EC: 2.7.1.37
UniProt & NIH Common Fund Data Resources
Find proteins for P49841 (Homo sapiens)
Explore P49841 
Go to UniProtKB:  P49841
PHAROS:  P49841
GTEx:  ENSG00000082701 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP49841
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
IXM
Query on IXM

Download Ideal Coordinates CCD File 
C [auth A],
D [auth B]
(Z)-1H,1'H-[2,3']BIINDOLYLIDENE-3,2'-DIONE-3-OXIME
C16 H11 N3 O2
HBDSHCUSXQATPO-BGBJRWHRSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
IXM BindingDB:  1Q41 IC50: min: 22, max: 200 (nM) from 3 assay(s)
PDBBind:  1Q41 IC50: 22 (nM) from 1 assay(s)
Binding MOAD:  1Q41 IC50: 22 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.229 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 83.438α = 90
b = 86.443β = 90
c = 178.825γ = 90
Software Package:
Software NamePurpose
SCALEPACKdata scaling
CNXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2003-10-21
    Type: Initial release
  • Version 1.1: 2008-04-29
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2023-08-16
    Changes: Data collection, Database references, Derived calculations, Refinement description